317 related articles for article (PubMed ID: 24910708)
1. Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?
Dey M; Auffinger B; Lesniak MS; Ahmed AU
Future Virol; 2013 Jul; 8(7):675-693. PubMed ID: 24910708
[TBL] [Abstract][Full Text] [Related]
2. Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
Koks CA; De Vleeschouwer S; Graf N; Van Gool SW
J Cancer; 2015; 6(3):203-17. PubMed ID: 25663937
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.
Auffinger B; Ahmed AU; Lesniak MS
Front Oncol; 2013; 3():32. PubMed ID: 23443138
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice.
Soldozy S; Eichberg DG; Morell AA; Luther E; Lu VM; Higgins DMO; Patel NV; Shah AH; Hanft SJ; Komotar RJ; Ivan ME
Pathogens; 2023 Jun; 12(7):. PubMed ID: 37513708
[TBL] [Abstract][Full Text] [Related]
6. Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.
Kim J; Hall RR; Lesniak MS; Ahmed AU
Viruses; 2015 Nov; 7(12):6200-17. PubMed ID: 26633462
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine amide augments the therapeutic effect of neural stem cell-based antiglioma oncolytic virotherapy.
Kim CK; Ahmed AU; Auffinger B; Ulasov IV; Tobias AL; Moon KS; Lesniak MS
Mol Ther; 2013 Nov; 21(11):2063-73. PubMed ID: 23883863
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic adenoviruses: A thorny path to glioma cure.
Ulasov IV; Borovjagin AV; Schroeder BA; Baryshnikov AY
Genes Dis; 2014 Dec; 1(2):214-226. PubMed ID: 25685829
[TBL] [Abstract][Full Text] [Related]
9. Poxvirus oncolytic virotherapy.
Torres-Domínguez LE; McFadden G
Expert Opin Biol Ther; 2019 Jun; 19(6):561-573. PubMed ID: 30919708
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.
Yang C; Hua N; Xie S; Wu Y; Zhu L; Wang S; Tong X
Biomed Pharmacother; 2021 Jul; 139():111573. PubMed ID: 33894623
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral virotherapy for malignant brain tumors.
Nandi S; Lesniak MS
Expert Opin Biol Ther; 2009 Jun; 9(6):737-47. PubMed ID: 19456208
[TBL] [Abstract][Full Text] [Related]
12. [Oncolytic viruses for therapy of malignant glioma].
Sosnovtceva AO; Grinenko NF; Lipatova AV; Chumakov PM; Chekhonin VP
Biomed Khim; 2016 May; 62(4):376-90. PubMed ID: 27562991
[TBL] [Abstract][Full Text] [Related]
13. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic Viral Therapy for Mesothelioma.
Pease DF; Kratzke RA
Front Oncol; 2017; 7():179. PubMed ID: 28884088
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic virotherapy.
Russell SJ; Peng KW; Bell JC
Nat Biotechnol; 2012 Jul; 30(7):658-70. PubMed ID: 22781695
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
[TBL] [Abstract][Full Text] [Related]
17. Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.
Ahmed AU; Thaci B; Alexiades NG; Han Y; Qian S; Liu F; Balyasnikova IV; Ulasov IY; Aboody KS; Lesniak MS
Mol Ther; 2011 Sep; 19(9):1714-26. PubMed ID: 21629227
[TBL] [Abstract][Full Text] [Related]
18. Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.
Friedman GK; Raborn J; Kelly VM; Cassady KA; Markert JM; Gillespie GY
Front Oncol; 2013; 3():28. PubMed ID: 23450706
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation in Oncolytic Measles Virotherapy.
Dietz L; Engeland CE
Methods Mol Biol; 2020; 2058():111-126. PubMed ID: 31486034
[TBL] [Abstract][Full Text] [Related]
20. Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy?
Leske H; Haase R; Restle F; Schichor C; Albrecht V; Vizoso Pinto MG; Tonn JC; Baiker A; Thon N
Anticancer Res; 2012 Apr; 32(4):1137-44. PubMed ID: 22493342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
